Cancelled due to lack of patient Effect of early pulmonary training on lung function and quality of life for novel coronavirus pneumonia (COVID-19) patients

Effect of early pulmonary training on lung function and quality of life for novel coronavirus pneumonia (COVID-19) patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030014

Enrollment

Unknown

Registered

2020-02-20

Start date

2020-02-19

Completion date

Unknown

Last updated

2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:pulmonary training

control group:Conventional medication

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: pneumoniaits were diagnosed by chest CT findings and positive nucleic acid tests

Exclusion criteria

Exclusion criteria: Exclude patients with influenza, adenovirus and other upper respiratory tract infections

Design outcomes

Primary

Measure	Time frame
MRC breathlessness scale;6MWD;	—

Secondary

Measure	Time frame
SF-36 score;	—

Countries

China

Contacts

Public ContactCAI YU

Wuhan Fourth Hospital

caiy_kf@163.com+86 18702745799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026